PRESS-RELEASE ·Filed Mar 30, 2026
Press release · Earnings
Actionable Insight • Neutral
Traders should prepare for potential volatility around the April 21 earnings release. Given recent insider selling, any weak-than-expected results could trigger downward pressure on the stock.
Final — all horizons settled through T+60d
BBNX ▲ +67.86% at T+60d
NEUTRAL call +67.86% · α vs SPY +55.48% · entry $10.02 → $16.82
T+1d
-0.10%
call -0.10% · α -0.85%
$10.01
settled 7mo ago
T+5d
-2.30%
call -2.30% · α -6.24%
$9.79
settled 7mo ago
T+20d
-2.89%
call -2.89% · α -12.32%
$9.73
settled 6mo ago
T+60d
+67.86%
call +67.86% · α +55.48%
$16.82
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Beta Bionics announced it will release its Q1 2026 financial results on April 21, 2026, followed by a conference call. The press release contains no financial data, only logistical details about the earnings announcement.
Key Facts
- Beta Bionics will release Q1 2026 financial results on April 21, 2026, after market close.
- Management will host a conference call and webcast on April 21 at 4:30 PM ET.
- No financial results or guidance were disclosed in this announcement.
- Recent insider activity shows 6 sell transactions totaling $100K in the past 30 days.
Financial Impact
No financial data disclosed
Risk Factors
- Earnings could miss expectations given lack of positive pre-announcement signals.
- Insider selling may indicate lack of confidence ahead of results.
Market Snapshot
Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3265020 |
24 reports for BBNX
56% Hit rate @ T+20 Went positive at some point 8 of 9 best @ T+60▲ +41.72%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $20.50 | awaiting T+20 | — | $21.39 (+4.34%) |
Oct 27, 2026 today | Press Release | $20.27 | awaiting T+20 | — | $21.39 (+5.53%) |
Oct 7, 2026 20d ago | SC 13G | $18.08 | awaiting T+20 | — | $21.39 (+18.31%) |
Sep 23, 2026 4w ago | Insider Cluster | $21.76 $19.34 | ▲ +11.12% | ▲ +10.70% | $21.39 (+1.70%) |
Sep 18, 2026 5w ago | Insider Cluster | $22.04 $16.84 | ▲ +23.59% | ▲ +22.69% | $21.39 (+2.95%) |
Sep 17, 2026 5w ago | Press Release | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $21.39 (−2.28%) |
Sep 17, 2026 5w ago | Insider Cluster | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $21.39 (−2.28%) |
Sep 15, 2026 5w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $21.39 (+3.56%) |
Sep 15, 2026 6w ago | 8-K | $22.18 $16.87 | ▼ −23.94% | ▼ −26.00% | $21.39 (−3.56%) |
Sep 15, 2026 6w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $21.39 (+3.56%) |
Showing 10 of 24
US Market Status
Market Closed — Opens Thu (9h 43m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers